Viewing Study NCT01779050


Ignite Creation Date: 2025-12-24 @ 5:23 PM
Ignite Modification Date: 2026-02-06 @ 12:05 PM
Study NCT ID: NCT01779050
Status: TERMINATED
Last Update Posted: 2022-11-01
First Post: 2013-01-25
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells
Sponsor: Washington University School of Medicine
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Neoplasms View
Keywords: